+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-12-01Number of Pages: 154

Life Sciences BPO Market (Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Clinical Data Management, Regulatory Services, Clinical Monitoring, Biostatistics, Protocol Development, and Site Management); Contract Manufacturing Organizations (Active Pharmaceutical Ingredient Manufacturing, Final Dosage Form Manufacturing, and Packaging); Contract Sales and Marketing Organizations; and Others (Payers and Providers))- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

The life sciences BPO market comprises services offered by CMOs (Contract Manufacturing Organizations) and CROs (Contract Research Organizations) to the biotech pharmaceutical companies. A rise in demand for low cost drugs, patent expirations and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This support has facilitated pharma players to streamline their value chain and focus more on its core strategies.

Each of the segments has been analyzed in detail for market trends, recent developments, outlook, and opportunities. The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that currently have strong impact on the global life sciences BPO market and could influence the market in the future as well. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition between leading market players operating across the globe. Porter’s five forces analysis is also explained in this section to understand the market considering different parameters that have an impact on the sustainability of the companies operating in the market. Additionally, a detailed value chain analysis for different components of the CRO and CMO have been covered to provide a comprehensive view of the industry. The report also mentioned about leading players for each of the sub-segments such as clinical trial, API manufacturing, vaccines, injectable among others.

All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their respective market shares. The recommendations section included in the report would assist existing market players in targeting all major stake holders of this industry such as companies, payers, providers, patients, government agencies and also to those aiming to seek an entry. The report also profiles major players in the global life sciences BPO market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments.

Key players in the life sciences BPO market include: Accenture plc, Anthelio Healthcare Solutions, Boehringer Ingelheim GmbH, Catalent, Inc., Cognizant Technology Solutions, Covance, Inc. Genpact Limited, ICON plc, Infosys Limited, International Business Machines Corporation, Lonza Group, PAREXEL International Corporation, Quintiles Transnational Corporation, and Wipro Limited.

The Global Life Sciences BPO market has been segmented as follows:

  • Global Life Sciences BPO Market, by Services
    • Pharmaceutical outsourcing
      • Contract Research Organizations
        • Drug Discovery
        • Preclinical Studies
        • Clinical Trials
        • Medical Writing
        • Pharmacovigilance
        • Clinical Data Management
        • Regulatory Services
        • Clinical Monitoring
        • Biostatistics
        • Protocol Development
        • Site Management
      • Contract Manufacturing Organizations
        • Active Pharmaceutical Ingredients
        • Finished Dose Form Manufacturing
        • Packaging
      • Contract Sales and Marketing Organizations
    • Others (Payers and Providers)
       
  • Global Life Sciences BPO Market, by Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • Rest of the Europe
    • Asia Pacific
      • China
      • India
    • Rest of the World
      • Latin America
      • Middle East and Africa


Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology 
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Life Sciences BPO Market 
2.2 Comparative Analysis, Global Life Sciences BPO Market Share, by Geography, 2014 & 2023E
2.3 Global Life Sciences BPO Market, by Contract Manufacturing Organizations, 2014

Chapter 3 Market Overview
3.1 Introduction
3.2 Drivers
       3.2.1 Inclination of Pharmaceutical and Biotechnology Companies Towards Core   Business Segments
       3.2.2 Patent Expirations to Boost CMO Industry Growth
       3.2.3 Orphan Drug Development to Drive CMO Market
3.3 Restraints
       3.3.1 Quality Issues and Risk of Information Breach 
3.4 Opportunities
       3.4.1 Targeting Biologics and Biosimilar Manufactures 
       3.4.2 Focus on Emerging Markets
3.5 Porter’s Five Force Analysis, Global Life Sciences BPO Market
3.6 Value Chain Analysis, Global Life Science Market 
       3.6.1 Value Chain Analysis, by Pharmaceutical Outsourcing
       3.6.2 Value Chain Analysis, by Medical Writing
       3.6.3 Value Chain Analysis, by Pharmacovigilance
       3.6.4 Value Chain Analysis, by Clinical Data Management
       3.6.5 Value Chain Analysis, by Regulatory Services
       3.6.6 Value Chain Analysis, by Clinical Monitoring
       3.6.7 Value Chain Analysis, by Bio-Statistics
       3.6.8 Value Chain Analysis, by Protocol Development
       3.6.9 Value Chain Analysis, by Site Management
3.7 Market Attractiveness Analysis, By Geography (2014)
3.8 List of Key market players in CMO and CRO

Chapter 4 Global Life Sciences BPO Market, By Service
4.1 Introduction
4.2 Pharmaceutical Outsourcing
       4.2.1 Contract Manufacturing 
                4.2.1.1 Global Active Pharmaceutical Ingredients Contract Manufacturing Market Revenue, 2013–2023 (US$ Bn)
                4.2.1.2 Global Finished Dose Form Contract Manufacturing Market Revenue, 2013–2023 (US$ Bn)
                4.2.1.3 Global Packaging Contract Manufacturing Market Revenue, 2013–2023 (US$ Bn) 
       4.2.2 Contract Research Organizations
                4.2.2.1 Global Drug Discovery Contract Research Market Revenue, 2013–2023 (US$ Bn) 
                4.2.2.2 Global Preclinical Studies Contract Research Market Revenue, 2013–2023 (US$ Bn)
                4.2.2.3 Global Clinical Trial Studies Contract Research Market Revenue, 2013–2023 (US$ Bn) 
                4.2.2.4 Global Medical Writing Contract Research Market Revenue, 2013–2023 (US$ Bn) 
                4.2.2.5 Global Pharmacovigilance Contract Research Market Revenue, 2013–2023 (US$ Bn)
                4.2.2.6 Global Clinical Data Management Contract Research Market Revenue, 2013–2023 (US$ Bn)
                4.2.2.7 Global Regulatory Services Contract Research Market Revenue, 2013–2023 (US$ Bn)
                4.2.2.8 Global Clinical Monitoring Contract Research Market Revenue, 2013–2023 (US$ Bn)
                4.2.2.9 Global Biostatistics Contract Research Market Revenue, 2013–2023 (US$ Bn)
                4.2.2.10 Global Protocol Development Contract Research Market Revenue, 2013–2023 (US$ Bn)
                4.2.2.11 Global Site Management Contract Research Market Revenue, 2013–2023 (US$ Bn)
       4.2.3 Contract Sales and Marketing Organizations
                4.2.3.1 Global Contract Sales and Marketing Outsourcing Market Revenue, 2013–2023 (US$ Bn)
4.3 Others (Payers and Providers)
       4.3.1 Global Other Outsourcing Services Market Revenue, 2013–2023 (US$ Bn)

Chapter 5 Geography
5.1 Introduction
       5.1.1 North America Life Sciences BPO Market Revenue, 2013–2023 (US$ Bn)
       5.1.2 Europe Life Sciences BPO Market Revenue, 2013–2023 (US$ Bn) 
       5.1.3 Asia Pacific Life Sciences BPO Market Revenue, 2013–2023 (US$ Bn)
       5.1.4 Rest of the World Life Sciences BPO Market Revenue, 2013–2023 (US$ Bn)

Chapter 6 Recommendations

Chapter 7 Company Profiles
7.1 Accenture plc
7.2 Anthelio Healthcare Solutions 
7.3 Boehringer Ingelheim GmbH
7.4 Catalent, Inc. 
7.5 Cognizant Technology Solutions 
7.6 Covance, Inc.
7.7 Genpact Limited 
7.8 ICON plc 
7.9 Infosys Limited 
7.10 International Business Machines Corporation 
7.11 Lonza Group
7.12 PAREXEL International Corporation 
7.13 Quintiles Transnational Corporation
7.14 Wipro Limited

In current market scenario, strategic outsourcing services play an important role in addressing various challenges faced by pharmaceutical companies such as stagnant productivity volume, regulatory changes, pricing pressures and thinner profit margins. Strategic outsourcing has become an industry norm and offers a wide range of services from screening and lead identification to toxicology, pre-clinical studies, clinical trials, manufacturing and marketing. Pharmaceutical outsourcing market, particularly contract manufacturing organizations (CMO), contract research organizations (CRO) and insurance/payer based services market has evolved over the recent years and expected foresee a healthy growth in the coming decade. 

Nowadays, outsourcing has become a feasible and a beneficial business strategy for pharmaceutical, biotechnology and life sciences industries that enables them to transfer non-core activities to outsourcing partners in order to focus on their distribution networks, competitive advantage, future growth, marketing strategies and issues imperative to survival. Earlier, outsourcing was considered as a cost saving business strategy by most of the pharmaceutical companies, but now it has evolved as a strategic competitive requirement to meet growing demands, offer flexibility in production and enhance company’s competitive advantage.

The global life sciences BPO market has been studied from two broad perspectives: by Services and by Geography. The services market is further segmented into pharmaceutical outsourcing and others. The pharmaceutical outsourcing market encompasses CRO, CSO, and CMO; whereas the Others segment provides a cumulative market for payers and provider based services that are primarily outsourced. This market holds immense growth owing to the rise in demand for generic drugs, increase in R&D investment by life sciences companies. In addition, a rise in the number of block buster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market. 

The CMO market comprises contract API (Active Pharmaceutical Ingredients) manufacturing, contract FDF (Finished Dosage Formulations) manufacturing and packaging. Among these, contract FDF manufacturing segment is expected to have a healthy growth rate during the forecast period. The CRO market is also expected to display a healthy growth rate after CMO market. The CRO market comprises of various segments such as drug discovery, pre-clinical studies, clinical trial phases, medical writing, clinical data management, pharmacovigilance, regulatory services, site management, protocol development, monitoring and bio-statistics. Among these, clinical data management segment is expected to have a strong growth rate in coming years. This growth has been attributed to its high data complexities, high cost involvement and requirement of skilled & trained professionals.

Geographically, the North American region constituted the largest market for global life sciences BPO market in 2014; however, Asia-Pacific is predicted to foresee the highest growth rate of over 14.6% from 2015 to 2023. This growth has been attributed to favorable government regulations, improved intellectual property protection rights and increased adoption of novel technologies. In addition, tax benefits, low labor costs and other overheads and availability of skilled professionals at a very low cost compared to developed nations would trigger the growth of this market in Asia-Pacific region.

Key players in the life sciences BPO market include: Accenture plc, Anthelio Healthcare Solutions, Boehringer Ingelheim GmbH, Catalent, Inc., Cognizant Technology Solutions, Covance, Inc. Genpact Limited, ICON plc, Infosys Limited, International Business Machines Corporation, Lonza Group, PAREXEL International Corporation, Quintiles Transnational Corporation, and Wipro Limited.

life-sciences-bpo-market

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries